29 June 2025
Read about the Clicks interim results that reveal a 13.2% rise in headline earnings per share and significant market achievements.
5 July 2024
Following a Constitutional Court ruling, Clicks Group plans to sell its shareholding in Unicorn Pharmaceuticals, enabling new pharmacy license applications.